Search the Library

Restrict food intake Laparoscopic gastric banding Sleeve gastrectomy Malabsorptive Reduce calorie absorption Jejunocolic bypass Combined Both Roux-en-Y gastric bypass Biliopancreatic diversion with duodenal switch Page 89General patient outcomes after bariatric surgical procedures have traditionally been thought to vary

restrict oral or enteral intake: bowel rest Ischemic bowel Mesenteric artery stenosis, intestinal angina, abdominal compartment syndrome, or low flow states Severe pancreatitis Increased pain or serum lipase levels with EN, infected pancreatic phlegmon or pseudocyst, complex pancreatic fistula, or abdominal compartment syndrome Chylous fistula Increased

diet, particularly of branched-chain amino acids. This is accomplished by using a metabolic formula that is low in leucine, isoleucine, and valine and supplementing with small calculated amounts of valine and isoleucine. Some forms of MSUD are responsive to high dosing of thiamine supplementation, since thiamine

diet, particularly of branched-chain amino acids. This is accomplished by using a metabolic formula that is low in leucine, isoleucine, and valine and supplementing with small calculated amounts of valine and isoleucine. Some forms of MSUD are responsive to high dosing of thiamine supplementation, since thiamine

diet, particularly of branched-chain amino acids. This is accomplished by using a metabolic formula that is low in leucine, isoleucine, and valine and supplementing with small calculated amounts of valine and isoleucine. Some forms of MSUD are responsive to high dosing of thiamine supplementation, since thiamine

caloric intake by 50%. Restrict fluid volume and sodium as needed. Advance PN formula if electrolytes

diet, particularly low in lysine and tryptophan; this is accomplished by supplementing with a metabolic formula that is low in tryptophan and lysine and enriched in arginine. Patients are also treated with levocarnitine to facilitate the excretion of toxic metabolites. Finally, during illnesses, intact protein is further

diet, particularly low in lysine and tryptophan; this is accomplished by supplementing with a metabolic formula that is low in tryptophan and lysine and enriched in arginine. Patients are also treated with levocarnitine to facilitate the excretion of toxic metabolites. Finally, during illnesses, intact protein is further

diet, particularly low in lysine and tryptophan; this is accomplished by supplementing with a metabolic formula that is low in tryptophan and lysine and enriched in arginine. Patients are also treated with levocarnitine to facilitate the excretion of toxic metabolites. Finally, during illnesses, intact protein is further

calorie, fluid, electrolyte, and micronutrient requirements and monitors response to therapy. Provides recommendations for the PN administration schedule. Completes appropriate diet education. Plays a vital role in the patient’s transition to oral or enteral nutrition therapy (eg, recommending enteral nutrition formula and prescription